Colorectal cancer is one of the leading cancers in Puerto Rican, second only to prostate and breast cancer. Inflammatory bowel diseases such as ulcerative colitis and Crohn's disease have been linked to the development of colorectal cancer. Evidence obtained by us and others have suggested that substance P (SP) and its high affinity receptor neurokinin-1 receptor (NK-1R, tachykinin receptor 1) play a pivotal role in inflammatory bowel diseases. Both NK-1R and cyclooxygenase-2 (Cox-2) are upregulated in patients with inflammatory bowel diseases. However, the roles of NK-1R-mediated signaling pathways in the pathogenesis of precancerous and cancerous lesions in ulcerative-associated colorectal cancer are not known. The long-term goals of this research project are to understand molecular mechanisms of ulcerative colitis-associated colorectal cancer and to target key signaling molecules in the development of ulcerative colitis-associated colorectal cancer for preventive and therapeutic intervention. The current study is designed to test the central hypothesis that NK-1R plays a key role in up regulation of Cox-2 in our rat model of colitis-associated dysplasia, and that the epidermal growth factor receptor (EGFR) and Src family tyrosine kinases (SFKs) are involved in NK-1R signaling in colon carcinoma cells, and in the development of precancerous lesions in this model of colitis-associated dysplasia.
Three specific aims will be pursued in this collaborative research project that combines the strength of Dr. Appleyard in the rat model of ulcerative colitis-associated colorectal cancer and the expertise of Dr. Wu in growth factor receptor and G protein-coupled receptor (GPCR) signaling. In addition to giving novel insights into the roles of NK-1R and its mediators in the development of colorectal cancer, this collaborative research project will provide Dr. Appleyard with an excellent platform to strengthen her competitiveness in the areas of biochemical and molecular cancer research. This in turn will increase the likelihood for Dr. Appleyard in the Minority-Serving Institute (MSI) to successfully compete for a R01 grant from the National Cancer Institute (NCI) and will increase the quality of graduate education at the MSI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory Grants--Cooperative Agreements (U56)
Project #
5U56CA118809-05
Application #
7930659
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O1))
Program Officer
Ogunbiyi, Peter
Project Start
2006-09-26
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
5
Fiscal Year
2010
Total Cost
$454,725
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Jiménez, Julio; Ramos, Axel; Ramos-Rivera, Francisco E et al. (2018) Community Engagement for Identifying Cancer Education Needs in Puerto Rico. J Cancer Educ 33:12-20
Seijo, Edward; Lima, Diana; Iriabho, Egiebade et al. (2016) Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations. Cancer Control 23:383-389
Dyer, Karen E; Quinn, Gwendolyn P (2016) Cancer and fertility preservation in Puerto Rico: a qualitative study of healthcare provider perceptions. Support Care Cancer 24:3353-60
Dyer, Karen E (2015) ""Surviving is not the same as living"": cancer and Sobrevivencia in Puerto Rico. Soc Sci Med 132:20-9
Menzie, Nicole S; Simmons, Vani N; Quinn, Gwendolyn P et al. (2015) Acceptability and Cultural Appropriateness of Self-Help Booklets for Relapse Prevention in Puerto Rico. J Cancer Educ 30:585-92
Quinn, Gwendolyn P (2014) Improving cancer clinical research and trials with Hispanic populations: training and outreach efforts between Moffitt Cancer Center and the Ponce School of Medicine. Rev Recent Clin Trials 9:223-4
Appleyard, Caroline B; Antonia, Scott J; Sullivan, Daniel M et al. (2014) Building a long distance training program to enhance clinical cancer research capacity in Puerto Rico. Rev Recent Clin Trials 9:254-62
Quinn, Gwendolyn P; McIntyre, Jessica; Gonzalez, Luis E et al. (2013) Improving awareness of cancer clinical trials among Hispanic patients and families: audience segmentation decisions for a media intervention. J Health Commun 18:1131-47
Engel, B E; Welsh, E; Emmons, M F et al. (2013) Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors. Cell Death Dis 4:e938
Chen, Lu; Chen, Dung-Tsa; Kurtyka, Courtney et al. (2012) Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem 287:40106-18

Showing the most recent 10 out of 25 publications